← Eichor
Condition: Opioid Use Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Opioid Use Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

tDCS to Decrease Opioid Relapse (UH3)
NA · 1 location(s) · Butler Hospital · NCT06432465Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Phase 2 · 1 location(s) · Johns Hopkins University · NCT05145764Semaglutide for Helping Opioid Recovery
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT06639464SAVE Trial: SAfe Opioid Use Video Education
NA · 1 location(s) · University of Utah · NCT07044583Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Phase N/A · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT06552741Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
Phase 1 · 1 location(s) · University of Minnesota · NCT07158853Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
NA · 1 location(s) · Korea University Guro Hospital · NCT07102446Translation and Validation of the COMM and ASI-SR
Phase N/A · 1 location(s) · Uppsala University · NCT06084520AvertD Post-Approval Study
Phase N/A · 1 location(s) · Prescient Medicine Holdings, Inc. · NCT07135323Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
NA · 1 location(s) · Potomac Health Foundations · NCT06774248Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
NA · 1 location(s) · Prisma Health-Upstate · NCT07202039Standard Versus High Dose ED-Initiated Buprenorphine Induction
Phase 3 · 5 location(s) · Yale University · NCT06494904Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826Sensory Outcomes in Active Substance Users
Phase N/A · 1 location(s) · Boston Medical Center · NCT06639438Virtual Intelligence for Transformative Lifestyle Solutions in Pain
NA · 1 location(s) · Montefiore Medical Center · NCT07124598A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Phase 3 · 1 location(s) · University of California, San Francisco · NCT05010148Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
NA · 1 location(s) · Friends Research Institute, Inc. · NCT06573476Vanderbilt Integrated Community TMS for Opioid Recovery
NA · 2 location(s) · Vanderbilt University Medical Center · NCT07457489Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Phase 3 · 6 location(s) · Emory University · NCT05834478Optimization of NIBS for Treatment of Addiction
NA · 3 location(s) · Case Western Reserve University · NCT04379115Longitudinal Neural Fingerprinting of Opioid-use Trajectories
NA · 1 location(s) · Yale University · NCT06207162Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
NA · 1 location(s) · Chestnut Health Systems · NCT06852170Assessing Optimal XRB Initiation Points in Jail
Phase 4 · 4 location(s) · NYU Langone Health · NCT06051890Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
Phase N/A · 1 location(s) · Ilana Hull · NCT05942313Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
NA · 1 location(s) · University of Pittsburgh · NCT06806163Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Phase 2 · 1 location(s) · University of Calgary · NCT04939623Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department
NA · 1 location(s) · University of California, San Francisco · NCT06872190Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
NA · 4 location(s) · University of Maryland, College Park · NCT05973838OUD (Opioid Use Disorder) Target Trial
NA · 1 location(s) · Duke University · NCT06585709
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.